Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
The current price of Eli Lilly And Co in the market is 50 874,38 ₴, with a 24-hour trading volume of 99,04B ₴. The asset's market cap is 45,36T ₴, after moving -2.41% in the last day.
Tokenized Eli Lilly And Co is trading at 51 099,64 ₴, with a tokenized market cap of 2B ₴ and a 24-hour trading volume of 122,37M ₴. The tokenized asset has moved -2.49% in the past 24 hours.